Total pancreatectomy: Short- and long-term outcomes at a high-volume pancreas center

Table 1 Demographics for 103 patients undergoing total pancreatectomy with subgroup analysis

Variable	Overall (n = 103)	PDAC (n = 42)	IPMN (n = 40)	LTP (n = 24)
Age, yr1	70.2 (32-84.5)	70.3 (33.3-84.5)	71.3 (42.9-81.1)	70.3 (37.3-84.5)
Body mass index1	25.1 (17.7-42.1)	24.2 (17.7-39.8)	25.8 (18.5-42.1)	26.7 (17.7-36.3)
Male	44 (42.7%)	18 (42.9%)	19 (47.5%)	13 (54.2%)
Hypertension	70 (68%)	29 (69%)	31 (77.5%)	14 (58.3%)
Diabetes	46 (44.7%)	19 (45.2%)	16 (40%)	13 (54.2%)
Cardiac disease	31 (30.1%)	8 (19%)	14 (35%)	7 (29.2%)
Pulmonary disease	19 (18.4%)	7 (16.7%)	7 (17.5%)	5 (20.8%)
ASA
II	24 (23.3%)	11 (26.2%)	9 (22.5%)	2 (8.3%)
III	72 (69.9%)	26 (61.9%)	29 (72.5%)	22 (91.7%)
IV	7 (6.8%)	5 (11.9%)	2 (5%)	0
Type of resection
Standard	35 (34%)	17 (40.5%)	10 (25%)	5 (20.8%)
Pylorus preserving	56 (54.4%)	20 (47.6%)	27 (67.5%)	16 (66.7%)
Completion	12 (11.6%)	5 (11.9%)	3 (7.5%)	3 (12.5%)

¹Values are median (range), values in parenthesis are percentages unless otherwise indicated. ASA: American Society of Anesthesiologists score; IPMN: Intraductal papillary mucinous neoplasm; LTP: Laparoscopic total pancreatectomy; PDAC: Pancreatic ductal adenocarcinoma.